Acute Ischemic Stroke

Cerebrovascular Ultrasound in Stroke Prevention and Treatment

Volumn , Issue , 2008, Pages 170-180

  Demchuk, Andrew M ^a   Alexandrov, Andrei V ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Arterial occlusion; Computed tomography (CT); Ischemic stroke; Occlusion; Reperfusion strategies

Indexed keywords

ACUTE ISCHEMIC STROKE; ARTERIAL OCCLUSIONS; ISCHEMIC STROKES; OCCLUSION; REPERFUSION;

COMPUTERIZED TOMOGRAPHY;

EID: 33846605511     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470752883.ch10     Document Type: Chapter

References (55)

1. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
2. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42:289-98.
3. Heiss W-D, Grond M, Thiel A, von Stockhausen H-M, Rudolf J, Ghaemi M, Lottgen J, Stenzel C, Pawlik G. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998; 18: 1298-307.
4. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of complete recanalization and dramatic clinical recovery during TPA infusion when continuously monitored by 2 MHz transcranial Doppler monitoring. Stroke 2000; 31: 610-4.
5. Molina C, Montaner J, Abilleira S, Arenillas JF, Ribo M, Huertas R, Romero F, Alvarez-Sabin J. Time course of tissue plasminogen activator-induced recanalization in acute cardio-embolic stroke: a case-control study. Stroke 2001; 32: 2821-7.
6. Caplan LR, Mohr JP, Kistler JP, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysisanot a panacea for ischemic stroke. N Engl J Med 1997; 337: 1309-10.
7. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000; 355: 1670-4.
8. Barber PA, Demchuk AM, Hudon ME, Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA 'dot' sign: a CT marker of acute ischemia. Stroke 2001; 32:84-8.
9. Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W. Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 1998; 29: 935-8.
10. Kenton AR, Martin PJ, Abbott RJ, Moody AR. Comparison of transcranial color-coded sonography and magnetic resonance angiography in acute stroke. Stroke 1997; 28: 1601-6.
11. Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke 2001; 32: 2460.
12. Alexandrov AV, Demchuk AM, Wein TH, Grotta JC. The yield of transcranial Doppler in acute cerebral ischemia. Stroke 1999; 30: 1605-9.
13. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within six hours. J Neurol Sci 1989; 91: 311-22.
14. Zanette EM, Fieschi C, Bozzao L, Roberti C, Toni D, Argentino C, Lenzi GL. Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke 1989; 20: 899-903.
15. Kaps M, Link A. Transcranial sonographic monitoring during thrombolytic therapy. Am J Neuroradiol 1998; 19:758-60.
16. Razumovsky AY, Gillard JH, Bryan RN, Hanley DF, Oppenheimer SM. TCD, MRA, and MRI in acute cerebral ischemia. Acta Neurol Scand 1999; 99: 65-76.
17. Burgin WS, Malkoff M, Felberg RA, Demchuk AM, Christou I, Grotta JC, Alexandrov AV. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 2000; 31: 1128-32.
18. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000; 10: 1-12.
19. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, Alexandrov AV. Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion with transcranial Doppler. Stroke 2000; 31: 140-6.
20. Alexandrov AV, Demchuk AM, Felberg RA, Grotta JC, Krieger D. Intracranial clot dissolution is associated with embolic signals on transcranial Doppler. J Neuroimaging 2000; 10: 27-32.
21. Alexandrov AV, Felberg RA, Demchuk AM, Christou I, Burgin WS, Malkoff M, Wojner AW, Grotta JC. Deterioration following spontaneous improvement:sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000; 31: 915-9.
22. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with tissue plasminogen activator. Stroke 2001; 32: 89-93.
23. Christou I, Felberg RA, Demchuk AM, Grotta JC, Burgin WS, Malkoff M, Alexandrov AV. Accuracy parameters of a broad diagnostic battery for bedside transcranial Doppler to detect flow changes with internal carotid artery stenosis or occlusion. J Neuroimaging 2001; 11: 236-42.
24. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312: 932-6.
25. Anderson JL. Why does thrombolysis fail? Breaking through the reperfusion ceiling. Am J Cardiol 1997; 80:1588-90.
26. Hackworthy RA, Sorensen SG, Fitzpatrick PG, Barry WH, Menlove RL, Rothbard RL, Anderson JL. Dependence of assessment of coronary artery reperfusion during acute myocardial infarction on angiographic criteria and interobserver variability. Am J Cardiol 1988; 62: 538-42.
27. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282 (21): 2003-11.
28. Barnett SB, Ter Haar GR, Ziskin MC, Rott HD, Duck FA, Maeda K. International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med Biol 2000; 26: 355-66.
29. Demchuk AM, Wein TH, Felberg RA, Christou I, Alexandrov AV. Evolution of rapid middle cerebral artery recanalization during intravenous thrombolysis for acute ischemic stroke. Circulation 1999; 100: 2282-3.
30. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous TPA therapy: sonographic classification and short term improvement. Circulation 2001; 103: 2897-902.
31. Christou I, Burgin WS, Alexandrov AV, Grotta JC. Arterial status after intravenous TPA therapy for ischemic stroke: a need for further interventions. Int Angiol 2001; 20 (3): 208-13.
32. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke:Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-605.
33. Pexman JH, Barber PA, Hill MD et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am J Neuroradiol 2001; 22 (8): 1534-42.
34. Alexandrov AV, Grotta JC. Arterial re-occlusion after intravenous tissue plasminogen therapy for acute ischemic stroke. Neurology 2002; 59: 862-67.
35. Burgin WS, Alexandrov AV. Deterioration following improvement with TPA therapy: carotid thrombosis and re-occlusion. Neurology 2001; 56: 568-70.
36. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001; 32: 661-8.
37. Burgin WS, Wojner AW, Grotta JC, Alexandrov AV. NIH Stroke Scale as a predictor of clot presence, location, and persisting occlusion in candidates for thrombolysis. Stroke 2001; 32: 324 [abstract].
38. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC. Timing of recanalization after TPA therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31: 1812-6.
39. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86.
40. Trubestein R, Bernard HR, Etzel F, Sobbe A, Cremer A, Stumpff U. Thrombolysis by ultrasound. Clin Sci Mol Med 1976; 51: 697-8.
41. Tachibana K, Tachibana S. Ultrasonic vibration for boosting fibrinolytic effects of urokinase in vivo. Thromb Haemost 1981; 46: 211 [abstract].
42. Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78:1063-8.
43. Kondo I, Mizushige K, Ueda T, Masugata H, Ohmori K, Matsuo H. Histological observations and the process of ultrasound contrast agent enhancement of tissue plasminogen activator thrombolysis with ultrasound exposure. Jpn Circ J 1999; 63: 478-84.
44. Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS, Schwarz K, Marder VJ. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992; 90:2063-8.
45. Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995; 21: 419-24.
46. Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation 1998; 98: 1030-5.
47. Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Thromb Haemost 1999; 81: 605-12.
48. Rosenschein U, Gaul G, Erbel R, Amann F, Velasguez D, Stoerger H, Simon R, Gomez G, Troster J, Bartorelli A, Pieper M, Kyriakides Z, Laniado S, Miller HI, Cribier A, Fajadet J. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation 1999; 99: 26-9.
49. Akiyama M, Ishibashi T, Yamada T, Furuhata H. Lowfrequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery 1998; 43: 828-32.
50. Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol 1999; 25: 269-73.
51. Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993; 81: 2636-43.
52. Moehring MA, Voie AH, Spencer MP, Amory DW, Alexandrov AV. Investigation of transcranial Doppler (TCD) power output for potentiation of tissue plasminogen activator (tPA) therapy in stroke. Cerebrovasc Dis 2000; 10 (Suppl. 1): 9 [abstract].
53. Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M. Acceleration of thrombolysis with ultrasound through the cranium in a flow model. Ultrasound Med Biol 2000; 26: 889-95.
54. Grolimund P. Transmission of ultrasound through the temporal bone. In: Aaslid R, ed. Transcranial Doppler Sonography. Wien: Springer Verlag, 1986: 10-21.
55. Eggers J, Koch B, Meyer K, Konig I, Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 2003; 53: 797-800.